Research: EBV and Vitamin D

#MSBlog : What is the link between EBV and vitamin D deficiency? Can we square the circle? Epub : Salzer et al. Epstein-Barr virus antibodie...

Research: Movement Devices are not created Equal

Sandroff BM, Motl RW. Comparison of ActiGraph activity monitors in persons with multiple sclerosis and controls. Disabil Rehabil . 2013;35...

Tysabri reduces fatigue

Epub : Svenningsson et al. Natalizumab Treatment Reduces Fatigue in Multiple Sclerosis. Results from the TYNERGY Trial; A Study in the Real ...

Barriers to employment for MSers

#MSBlog : Given sufficient time MS causes the majority of MSers to become unemployed. Why? Epub : Carrieri et al. Determinants of on-the-jo...

Research: Low levels of Eye Problems after Gilenya treatment

Epub : Zarbin  et al. Ophthalmic Evaluations in Clinical Studies of Fingolimod (FTY720) in Multiple Sclerosis. Ophthalmology. 2013 Mar 23. ...

Sponsor a Dendrite to Make a Neuron

Queen Mary have an active Public Engagement programme and have the  Award winning,  Centre of the Cell  (orange blobs = dividing cell) that ...

Research: physical fitness and walking

Epub : Sandroff et al.  Physical fitness, walking performance, and gait in multiple sclerosis. J Neurol Sci. 2013 Mar . doi:pii: S0022-510X...

Brainstem involvement and sleep disorders in MS

#MSBlog : If you have had a brainstem attack you may be at risk of sleep abnormalities. "This is a reposting in response to an email I ...

Research: exercise is good for you

Epub : Tarakci E et al.  Group exercise training for balance, functional status, spasticity, fatigue and quality of life in multiple scleros...

STREAMS TRIAL: stem cells in rapidly evolving active MS

#MSBlog : Are you interested in an MS stem cell trial? This one may be for you.  The STREAMS (Stem cells in Rapidly Evolving Active Multiple...

Research: walking outcomes for trials

#MSBlog : Are you a biological walking machine? A walkbot? Epub : Freeman et al. Evaluating change in mobility in people with multiple scler...

Research: Interleukin-7 receptor influences immune disease

Epub : Ashbaugh et al. IL7Rα Contributes to Experimental Autoimmune Encephalomyelitis through Altered T Cell Responses and Nonhematopoietic ...

BG12 is effective within 12 weeks of starting treatment

#MSBlog : BG12 works within 12 weeks of starting treatment. Kappos et al. Timecourse of Treatment Effects of BG-12 (Dimethyl Fumarate) for R...

Have you discussed Artifical Reproduction Techniques

Epub : Hellwig & Correale. Artificial reproductive techniques in multiple sclerosis. Clin Immunol. 2013 Feb 15. doi:pii: S1521-6616(13)...

Research: persistence on MS therapies

#MSBlog : How will the orals affect persistence figures on MS DMTs? Epub : Jokubaitis et al.  The Australian Multiple Sclerosis (MS) Immunot...

Natalizumab-associated PML Update: March 2013

#MSBlog : March natalizumab PML update; 343 confirmed cases with a 23% mortality rate on a denominator of more than 112,000 treated MSers. ...

Survey results: MRI monitoring on natalizumab

"The following are the survey results regarding MRI monitoring of MSers on natalizumab for PML. The good news is that most MSers on nat...

Blog traffic by country

"Last month saw readers from the United States overtake the UK in terms of overall blog visits. This is surprising for us, as the blog ...

Research: JC virus antibodies

Epub : Warnke et al.   to anti-JCV antibody levels in a Swedish national MS cohort. J Neurol Neurosurg Psychiatry. 2013 Mar 5.  BACKGROUND :...

The Publication Fool

As of today all publications generated from UK government funded science have to be published in an "open source" publication. Est...

BG12 will cost $54,900 annually

Robert Weisman. Biogen Idec’s new pill to treat MS will cost about $54,900 per patient annually. Boston.com Biogen Idec Inc. said Friday it ...

On-line disease monitoring

#MSBlog : Has the era of on-line disease monitoring finally arrived? Not if you are a MSer under the care of the NHS. Epub : Bove et al. Eva...

Research Biomarker for Progression

Gnanapavan S, Ho P, Heywood W, Jackson S, Grant D, Rantell K, Keir G, Mills K, Steinman L, Giovannoni G. Progression in multiple sclerosis i...

Research: North South Gradients in Oz assessed by Drug use

Hollingworth S, Walker K, Page A, Eadie M. and the Australian regional prevalence of multiple sclerosis. Mult Scler. 2013. [Epub ahead of ...